Solutions
You will receive an email with a link to the webinar
Human umbilical cord blood and tissues are readily available and a rich source of cells with therapeutic potential, including the ability to modulate inflammation. In this encore Share the Science webinar held in honor of World Cord Blood Day, Dr. Filiano discusses two investigational cell therapies for inflammatory disease.
Cord blood contains a rich source of immune-modulating components including stem cells, immune cells, and soluble factors. Recent work has demonstrated the efficacy of using cord-blood derived components to promote myelination and increase function in neurological conditions such as multiple sclerosis, autism spectrum disorder, and aging.
Register to learn more about this promising research that could pave the way for new treatments of neuroinflammation.
This webinar was originally recorded earlier this year and will be presented again with additional video content not seen during the first presentation.
Register now and you will receive a link to the recording and slides.
Recorded Oct 23, 2018
WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.
Dr. Filiano’s research looks at how cord blood- and cord tissue-derived cell therapies can be used to treat inflammatory disease, in particular inflammatory disorders of the brain. The Filiano Lab is interested in understanding the complex interactions between the immune system and nervous system with the intent to uncover novel therapeutic targets to combat diseases. Dr. Filiano received his education and training from the University of Alabama at Birmingham, D.Phil, and the University of Virginia, where he was a Hartwell Fellow.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.